JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$2.97
-0.01 (-0.34%)
As of Sep 23, 10:50 PM ET ·
JUNS News3 articles
Jupiter Neurosciences Soars 59% on Massive Volume Spike
Jupiter Neurosciences (JUNS) jumped 59% on massive volume, trading at 58.8x its share count. Yet market cap remains far below Nasdaq's $35M threshold.
Markets
Jupiter Neurosciences Stock Retreats After Securing U.S. MDMA Rights
Jupiter Neurosciences shares fell from a 67% rally after securing U.S. rights for a trial-stage MDMA drug, with the stock rising only 6.2% amid concerns over financing and dilution.
Markets
Jupiter Neurosciences Shares Plunge on $100M MDMA Deal and Dilutive Offering
Jupiter Neurosciences shares fell 37% to $0.205 after announcing a $100M licensing deal for MDMA drug ALA-002 and a $2M stock offering, with trading volume exceeding 230 million shares.
Markets